The mechanisms underlying the limited response to immune checkpoint blockade (ICB) in most patients remain elusive. This study identifies GBP2 as a key enhancer of T cell-mediated ferroptosis and ICB efficacy through phase separation and STAT1 activation.
- Xin Liu
- Shilin Fang
- Haizhou Wang